Scandinavian ChemoTech AB (publ) (FRA:8V6)

Market Cap	7.44M
Revenue (ttm)	1.06M
Net Income (ttm)	-786.83K
Shares Out	n/a
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	11
Open	0.2690
Previous Close	0.2680
Day's Range	0.2690 - 0.2690
52-Week Range	0.0394 - 0.6800
Beta	n/a
RSI	29.79
Earnings Date	Mar 3, 2026

About Scandinavian ChemoTech AB

Scandinavian ChemoTech AB (publ) offers cancer care and pain management solutions in Sweden and Florida. The company offers IQWave, an electroporation device, used for electrochemotherapy and treatment of head and neck cancer, squamous cell carcinoma, malignant melanoma, basal cell carcinoma, adenocarcinoma of the breast and salivary gland, hypernephroma, kaposi sarcoma, and transitional cell carcinoma. It also offers Vetiqure for the treatment of superficial tumors in dogs, cats, and horses. The company markets its products through distributio...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2013
• Employees: 6
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 8V6

Financial Performance

In 2024, Scandinavian ChemoTech AB's revenue was 6.57 million, an increase of 132.67% compared to the previous year's 2.82 million. Losses were -13.72 million, -34.96% less than in 2023.

Financial numbers in SEK